Artificial Blood Vessels Industry Report, 2020-2025 - Stringent Regulatory Framework and High Costs are Hampering Growth
DUBLIN, Feb. 25, 2020 /PRNewswire/ -- The "Artificial Blood Vessels Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Research institutes have developed artificial blood vessels made from special polymers, that has exceptional mechanical properties.
Surgeons initially transplanted veins or arteries from donors to replace the damaged or diseased arteries from the human body. Transplanting vessels from the patient's own body has various problems such as development of arteriosclerosis and several post-surgery complications. Hence, to avoid such difficulties, artificial blood vessels were created by researchers, thus augmenting the market growth.
However, the presence of a stringent regulatory framework for the approval of artificial vessels will limit the market growth. Moreover, the high cost associated with transplants and surgeries will further impede the market growth.
Key Market Trends
Application in Aortic Disease is Expected to cover a Large Share of the Market
The aorta is the largest artery in the body. Oxygen-rich blood enters the aorta and the heart pumps the blood out of the aorta where it travels to the rest of the body via the smaller arteries that branch out from it. A variety of diseases and conditions can cause damage to the aorta and put patients at great, life-threatening risk. Those conditions include atherosclerosis, hypertension, genetic conditions, connective tissue disorders, and injury.
As per a report 2015 report by D. P. J. Howard et al., published in Wiley Online Library, the incidence of acute abdominal aortic aneurysm (AAA) events per 100 000 population per year was 55 in men aged between 65 and 74 years, but increased to 112 at age between 75 and 84 years and to 298 at age 85 years or above. Therefore as the geriatric population is increasing as per 2017 report on "World Aging Population" by the United Nations. Hence, the prevalence of aortic diseases is expected to increase in the future.
When an aneurysm ruptures, surgery is needed. Surgery thus involves removing the section of aorta where the aneurysm is and replacing it with an artificial blood vessel. Therefore with the increasing incidence, artificial blood vessels application is expected to increase and this, in turn, will help the market growth.
North America is Expected to Dominate the Artificial Blood Vessels Market
North America holds the major share of the market due to well-developed healthcare infrastructure, and technology advancements in this region.
Besides, the growing prevalence of aortic diseases in the U.S. is also likely to boost the market growth. As per the Center for Diseases Control and Prevention 2019 report, aortic aneurysms were the cause of 9,928 deaths in 2017 in the United States. The number of smokers, who are more prone to aortic diseases is also increasing in the US. Hence, the growing burden of such diseases will augment the artificial blood vessels market.
However, the United States also have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.
Competitive Landscape
Majority of the artificial blood vessels are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.
Key Topics Covered
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Aortic Diseases
4.2.2 Growing Adoption of Minimally Invasive Surgeries
4.2.3 Technological Advancements in Development of Artificial Blood Vessels
4.3 Market Restraints
4.3.1 High Cost Associated with Transplants and Surgeries
4.4 Porter's Five Force Analysis
5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Aortic Disease
5.1.2 Peripheral Artery Disease
5.1.3 Hemodialysis
5.2 By Polymer
5.2.1 Polydioxanone
5.2.2 Elastomer
5.2.3 Polyethylene Terephthalate
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.2 Europe
5.3.3 Asia-Pacific
5.3.4 Middle-East & Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen
6.1.2 Becton, Dickinson and Company
6.1.3 Cook Medical Incorporated
6.1.4 Humacyte Inc.
6.1.5 Jotec GmbH
6.1.6 LeMaitre Vascular Inc
6.1.7 Medtronic
6.1.8 Techshot Inc
6.1.9 Terumo Medical Corporation
6.1.10 W. L. Gore and Associates
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/jtprkl
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article